Keros Therapeutics, Inc.

UBS Group AG KROS
Report date
12/31/2025
Quarter
2025 Q4
Filed
1/29/2026
Shares
97,084
Value ($000)
1,977
Weight
0.0%
2020 Q2 - 2025 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).